Description
| Tolvaptan is a selective vasopressin V₂ receptor antagonist used to treat clinically significant hyponatremia (low blood sodium) and to slow kidney function decline in adults with rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). It functions as an “aquauretic,” promoting the excretion of free water without causing significant sodium loss |
Reviews
There are no reviews yet.